1701 K Street NW
Washington, DC 20006
It looks like nothing was found at this location. Maybe try the search below?
Rent Reporting Center
Disclaimer: This website is intended for general education and informational purposes only and should not be regarded as legal advice or a legal opinion. Every effort has been made to ensure that the information provided is up-to-date, however it is not intended to be a full and exhaustive explanation or representation of the rent reporting space, nor should it be used to replace the advice of your own legal counsel for any specific situation.
Get In Touch
“We feel that there is no better tasting and refreshing product in this category. Our water is clear of fluorides, chlorine, lead, and mercury that can sometimes be found in other waters. Holy Water goes through a proprietary 7-step purification process, including reverse osmoses and carbon filters to ensure the perfect result every time. Water is so vital to our bodies so it is of upmost importance to know what you are putting in it.” -Edward Quiroz, Co-CEO, Holy Grail Company.
TEMECULA, Calif., May 03, 2017 (GLOBE NEWSWIRE) — Holy Grail Company under its subsidiary HaenepSource, LLC is announcing the official release of Holy Water- a perfectly pH balanced Hemp (CBD) infused water. Developed by an exercise physiologist and his team of experts, Holy Water hydrates the body while feeding the endocannabinoid system (ECS).
For more information on the product please visit our website www.HolyGrailCompany.com
“The goal was to create a perfectly balanced water while including the power found in Holy Grail Hemp (CBD). One 16.9oz bottle contains one serving of Hemp (CBD), which is approximately 2.5mg. The hemp oil is a water soluble, nano-sized proprietary mixture. Since the mixture has been through our nano-process, the CBD has quicker bioavailability due to the particle size. We coupled this mixture with a 9+pH Alkaline water containing calcium, zinc, and potassium to create the perfect balance.” -Jason Golec, Co-CEO, Holy Grail Company.
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause Haenep’s actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. Haenep disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional uncertainties that could impact Haenep’s forward-looking statements, please see Haenep’s filings on OTC Markets.